CRISPR Therapeutics
Andrew J. Silver

Andrew J. Silver

Vice President Corporate Finance at CRISPR Therapeutics

About

Links

Org chart

Manager

Raju Prasad

CFO

Peers

Daniela Colombo

Senior Accounting Manager

Reports

Jesse Hernandez

Quality Product Lead, In Vivo Therapies

Katherine Galindo

Regulatory CMC Strategic Lead - In Vivo Pipeline

Mary Kathryn Cornwell

Associate Director, Reporting & Technical Accounting

Michael Harrison

Director, Quality Operations

Timeline

Vice President Corporate Finance
January, 2023 - present
Executive Director, Finance & Accounting
January, 2021
Senior Director, Reporting & Technical Accounting
February, 2020
Director, Reporting & Technical Accounting
October, 2018

View in org chart